1339 related articles for article (PubMed ID: 33995341)
1. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
Front Immunol; 2021; 12():589095. PubMed ID: 33995341
[TBL] [Abstract][Full Text] [Related]
2. Controlling Cytokine Storm Is Vital in COVID-19.
Tang L; Yin Z; Hu Y; Mei H
Front Immunol; 2020; 11():570993. PubMed ID: 33329533
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and inflammatory bowel disease: A pathophysiological assessment.
Yang C; Xiao SY
Biomed Pharmacother; 2021 Mar; 135():111233. PubMed ID: 33433350
[TBL] [Abstract][Full Text] [Related]
4. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
5. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword.
Tan LY; Komarasamy TV; Rmt Balasubramaniam V
Front Immunol; 2021; 12():742941. PubMed ID: 34659238
[TBL] [Abstract][Full Text] [Related]
6. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
[TBL] [Abstract][Full Text] [Related]
7. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
Pinheiro MM; Fabbri A; Infante M
Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
[TBL] [Abstract][Full Text] [Related]
8. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.
Root-Bernstein R
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
Front Immunol; 2021; 12():629193. PubMed ID: 33732251
[TBL] [Abstract][Full Text] [Related]
10.
Mardi A; Meidaninikjeh S; Nikfarjam S; Majidi Zolbanin N; Jafari R
Viral Immunol; 2021 Dec; 34(10):679-688. PubMed ID: 34882013
[TBL] [Abstract][Full Text] [Related]
11. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
Front Immunol; 2021; 12():749291. PubMed ID: 34867978
[TBL] [Abstract][Full Text] [Related]
12. Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications.
Hirawat R; Saifi MA; Godugu C
Life Sci; 2021 Feb; 267():118923. PubMed ID: 33358906
[TBL] [Abstract][Full Text] [Related]
13. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
Lupu L; Palmer A; Huber-Lang M
Front Immunol; 2020; 11():584514. PubMed ID: 33101314
[TBL] [Abstract][Full Text] [Related]
14. Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19.
Jeyaraman M; John A; Koshy S; Ranjan R; Anudeep TC; Jain R; Swati K; Jha NK; Sharma A; Kesari KK; Prakash A; Nand P; Jha SK; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166014. PubMed ID: 33232817
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence.
Pelaia C; Calabrese C; Garofalo E; Bruni A; Vatrella A; Pelaia G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802761
[TBL] [Abstract][Full Text] [Related]
16. Immune Responses to the Novel Coronavirus-2: Friend or Foe?
Mahmoodpoor A; Nader ND
Immunol Invest; 2021 Nov; 50(8):949-951. PubMed ID: 32689852
[No Abstract] [Full Text] [Related]
17. Cytokine storm syndrome in SARS-CoV-2: a review.
Wahid B; Rani N; Idrees M
Z Naturforsch C J Biosci; 2022 Jan; 77(1-2):65-69. PubMed ID: 34428364
[TBL] [Abstract][Full Text] [Related]
18. Immune dysregulation and system pathology in COVID-19.
Jamal M; Bangash HI; Habiba M; Lei Y; Xie T; Sun J; Wei Z; Hong Z; Shao L; Zhang Q
Virulence; 2021 Dec; 12(1):918-936. PubMed ID: 33757410
[TBL] [Abstract][Full Text] [Related]
19. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.
Gu T; Zhao S; Jin G; Song M; Zhi Y; Zhao R; Ma F; Zheng Y; Wang K; Liu H; Xin M; Han W; Li X; Dong CD; Liu K; Dong Z
Front Immunol; 2020; 11():621441. PubMed ID: 33584719
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.
Napodano C; Pocino K; Stefanile A; Marino M; Miele L; Gulli F; Basile V; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
Scand J Immunol; 2021 Mar; 93(3):e12977. PubMed ID: 32931622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
